PATENT CLAIM ANALYSIS

Application Number: 15745379
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "093200"]

Abstract:
Use of a rAAV3B vector to deliver gene products to human hepatocytes is described. The rAAV3B vectors achieve high levels of transduction even in the presence of pre-existing immunity to AAV8 or AAVrh10. Compositions and treatment regimens are described. Also provided are rAAV engineered to facilitate purification and methods of purifying the AAV.

Claim (Index 19):
The regimen according to  claim 17 , wherein the delivery of the first rAAV and the second rAAV are temporally separately by at least about 1 year to about 10 years.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.32558
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15681267', '15435212', '15862999', '15366863', '11793430']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8152693488672591
- 35 USC 102 Novelty (BERT): 0.5423378908572178
- Combined Prediction Score: 0.7879762030662549
- Mean Citation Score: 443.771756
- Max Citation Score: 467.72687
- Similarity Product: 222.98037348993543

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test